Home » Topics » BioWorld Science

BioWorld Science
RSS

COVA1-18 demonstrates strong antiviral activity against SARS-CoV-2 in vivo

Nov. 12, 2021

Boehringer Ingelheim presents new HER2 inhibitors

Nov. 12, 2021

New compounds inhibiting respiratory syncytial virus identified at Janssen

Nov. 12, 2021

Roche patents potassium voltage-gated channel subfamily C member 1 activators

Nov. 12, 2021

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Nov. 12, 2021

PharmaMar describes HER2-targeting antibody-drug conjugates

Nov. 12, 2021

Calreticulin as promising new therapeutic target in breast cancer

Nov. 12, 2021

SCO-spondin-derived peptide shows neuroprotection and increased synaptic transmission in the CNS

Nov. 12, 2021

FPR2 agonist NAP-1051 shows promise in preclinical SLE model

Nov. 12, 2021

Ascentage Pharma polycomb protein EED inhibitor displays potency, tumor regression potential

Nov. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...